Altimmune's Pemvidutide Gets Fast Track Designation by FDA: A Major Step Forward in the Treatment of Non-Alcoholic Steatohepatitis (NASH).
FDA Approves This Company For Breakthrough Liver Disease Treatment
FDA Approves This Company For Breakthrough…
FDA Approves This Company For Breakthrough Liver Disease Treatment
Altimmune's Pemvidutide Gets Fast Track Designation by FDA: A Major Step Forward in the Treatment of Non-Alcoholic Steatohepatitis (NASH).